2024Open access
Immunohistochemical Study on Programmed Death Ligand 1 (PD-L1) in Breast Carcinoma and its Correlation with the Clinicopathological ParametersQJM, Cancer Immunotherapy and Biomarkers
Active, last published 2026
In cancer immunotherapy and biomarkers
Zeinab A. Shehab
ElDin
“Research focused on Cancer Immunotherapy and Biomarkers and adjacent fields.”
Ain Shams UniversityEgypt
Claim Your Profile1
H-index
3
Citations
Zeinab has not officially claimed their profile. If you are Zeinab, claim it free.
Claim Your Profile01 · About the work
What I study
einab A. Shehab ElDin is a researcher working on Cancer Immunotherapy and Biomarkers. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Zeinab's work has been cited 3 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
05 · Research focus
Topics
Cancer Immunotherapy and Biomarkers×1Epigenetics and DNA Methylation×1CAR-T cell therapy research×1Genetic Syndromes and Imprinting×1Advanced Breast Cancer Therapies×1
06 · Where I am
Affiliations
CurrentlyAin Shams University, Egypt
Research themes (UN SDGs)
07 · Selected work
Recent publications
Are you Zeinab?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required